OLIPHARM
ActiveSummary
OLIPHARM has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €143,156 and a net result of €3,720. Equity is growing by about 55% per year across the filed financial years. Its solvency ranks better than 30% of 11,207 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €143,156
- Profit
- €3,720
- Holdings
- 11
Why 88raises riskEquity €143,156 (10.9% of total assets)Liquidity: current ratio 24.46, cash €5,429lowers riskSize: total assets €1.3mFigures for financial year 2025 (filed 04-08-2026)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro): better than 32% on solvency, 54% on liquidity, 34% on profitability and 54% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 41 days before the deadline; the sector median (NACE 68) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Back to profitnet €3,720
- Liquidity more than doubledcurrent ratio 24.46
Financials · financial year 2025, abbreviated format
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result returns to profit in 2025: €1,232 after a loss of €3,962 in 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 68, Real estate activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,780 | €4,080 | €0 | - | - | - | - | - | - |
| Other operating charges640/8 | - | - | - | €498 | €498 | €3,383 | €968 | €2,972 | ▲ 207% |
| Non-recurring operating charges66A | - | - | - | €0 | - | - | - | - | - |
| Gross operating margin9900 | -€9,698 | -€2,752 | €33,743 | -€12,010 | €5,986 | €55,270 | -€2,995 | €4,204 | - |
| Operating profit (loss)9901 | -€13,825 | -€7,179 | €20,455 | -€12,508 | €5,488 | €51,887 | -€3,962 | €1,232 | - |
| Financial income75/76B | - | - | - | - | €586 | €5,524 | €3,582 | €4,567 | ▲ 27.5% |
| Recurring financial income75 | €14 | €1 | €0 | - | €586 | €5,524 | €3,582 | €4,567 | ▲ 27.5% |
| Financial charges65/66B | - | - | - | €43 | €57 | €161 | €44 | €553 | ▲ 13× |
| Recurring financial charges65 | €909 | €852 | €763 | €43 | €57 | €161 | €44 | €553 | ▲ 13× |
| Profit (loss) for the period before taxes9903 | -€14,721 | -€8,030 | €19,692 | -€12,551 | €6,018 | €57,250 | -€424 | €5,246 | - |
| Income taxes67/77 | - | - | - | - | - | €13,145 | -€1 | €1,526 | - |
| Profit (loss) for the period9904 | -€14,721 | -€8,030 | €19,692 | -€12,551 | €6,018 | €44,104 | -€423 | €3,720 | - |
| Profit (loss) for the period to be appropriated9905 | -€14,721 | -€8,030 | €19,692 | -€12,551 | €6,018 | €44,104 | -€423 | €3,720 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.04m | €0.03m | €0.04m | €0.003m | €1.2m | €1.3m | €1.3m | €1.3m | ▲ 0.2% |
| Fixed assets21/28 | €0.03m | €0.03m | €0 | - | €1.2m | €1.2m | €1.2m | €1.2m | ▲ 0.1% |
| Tangible fixed assets22/27 | €0.03m | €0.03m | €0 | - | - | - | - | - | - |
| Financial fixed assets28 | €0.001m | €0.001m | €0 | - | €1.2m | €1.2m | €1.2m | €1.2m | ▲ 0.1% |
| Current assets29/58 | €0.008m | €0.001m | €0.04m | €0.003m | €0.03m | €0.1m | €0.1m | €0.1m | ▲ 1.4% |
| Amounts receivable within one year40/41 | €267 | €261 | €0.03m | €0.002m | €0.02m | €0.1m | €0.1m | €0.1m | ▲ 5.0% |
| Trade receivables40 | - | - | - | €0 | - | - | €0.003m | €0.001m | ▼ 52.4% |
| Other amounts receivable41 | - | - | - | €0.002m | €0.02m | €0.1m | €0.1m | €0.1m | ▲ 6.5% |
| Cash at bank and in hand54/58 | €0.008m | €0.001m | €0.01m | €0.001m | €0.004m | €0.01m | €0.009m | €0.005m | ▼ 41.9% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.04m | €0.03m | €0.04m | €0.003m | €1.2m | €1.3m | €1.3m | €1.3m | ▲ 0.2% |
| Equity10/15 | €27 | -€0.008m | €0.01m | -€0.001m | €0.08m | €0.1m | €0.1m | €0.1m | ▲ 2.7% |
| Contributions10/11 | €0.02m | €0.02m | - | €0.02m | €0.02m | €0.04m | €0.04m | €0.04m | = |
| Reserves13 | - | - | - | - | €0.002m | €0.05m | €0.05m | €0.05m | = |
| Distributable reserves133 | - | - | - | - | €0.002m | €0.05m | €0.05m | €0.05m | = |
| Profit (loss) carried forward14 | -€0.02m | -€0.03m | -€0.007m | -€0.02m | €0.06m | €0.06m | €0.06m | €0.06m | ▲ 6.5% |
| Amounts payable17/49 | €0.04m | €0.04m | €0.03m | €0.004m | €1.2m | €1.2m | €1.2m | €1.2m | ▼ 0.1% |
| Amounts payable after more than one year17 | €0.02m | €0.01m | €0 | - | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Other amounts payable178/9 | - | - | - | - | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Amounts payable within one year42/48 | €0.02m | €0.03m | €0.03m | €0.004m | €0.001m | €0.01m | €0.01m | €0.005m | ▼ 61.3% |
| Trade debts44 | €0.001m | - | - | €348 | €0.001m | €0 | - | €0.004m | - |
| Suppliers440/4 | - | - | - | €348 | €0.001m | €0 | - | €0.004m | - |
| Taxes, remuneration and social security45 | - | - | - | €0 | - | €0.01m | €0.01m | €0.002m | ▼ 88.4% |
| Taxes450/3 | - | - | - | €0 | - | €0.01m | €0.01m | €0.002m | ▼ 88.4% |
| Other amounts payable47/48 | - | - | - | €0.004m | €0 | - | - | - | - |
| Accrued charges and deferred income492/3 | - | - | - | - | - | - | - | €0.007m | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€14,721 | -€8,030 | €19,692 | -€12,551 | €6,018 | €44,104 | -€423 | €3,720 | - |
| + Depreciation and write-downs630 | €3,780 | €4,080 | €0 | - | - | - | - | - | - |
| Operating cash flow (approximation) | -€10,941 | -€3,950 | €19,692 | -€12,551 | €6,018 | €44,104 | -€423 | €3,720 | - |
| Investment in fixed assets (approximation) | - | -€1,500 | €31,941 | - | - | €22,247 | €4,771 | -€717 | - |
| Change in cash | - | -€7,069 | €10,036 | -€10,549 | €3,723 | €10,406 | -€5,326 | -€3,909 | ▲ 26.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 14 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 30-07-2026 | 2026-00377593 |
| 31-12-2024 | full format | 05-06-2025 | 2025-00138071 |
| 31-12-2023 | full format | 14-06-2024 | 2024-00145946 |
| 31-12-2022 | full format | 07-06-2023 | 2023-00120938 |
| 31-12-2021 | full format | 15-06-2022 | 2022-20079364 |
| 31-12-2020 | full format | 08-06-2021 | 2021-18900227 |
| 31-12-2019 | micro format | 29-06-2020 | 2020-26000316 |
| 31-12-2018 | micro format | 27-05-2019 | 2019-14500005 |
| 31-12-2017 | micro format | 31-07-2018 | 2018-41500411 |
| 31-12-2016 | micro format | 30-09-2017 | 2017-65600185 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.
Group and network
Holdings and subsidiaries
11 holdingsHoldings 11
Source for every holding own accounts 2025
- Equity €6,711Result €39,01033.9%
- Equity -€1.0mResult -€188,85933.01%
- Equity -€1.9mResult -€336,36320%
- Equity -€79,005Result -€9,72518%
- Equity -€458,628Result -€25,43815%
- Equity -€178,778Result -€18,12915%
- Equity -€44,658Result -€4815%
- Equity -€81,267Result -€12,35114.52%
- Equity -€171,615Result -€68,65810%
- Equity €3.1mResult €59,47510%
Show 1 more holdings
- Equity -€1.6mResult -€596,14110%
According to the 2025 annual accounts of OLIPHARM and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 1 of 5 Gazette acts processed.
History
Acts, filings and financial milestones
22-08
Gazette deed
Capital & shares · Amendment of the articles · RestructuringAuditor report · Capital contribution · Share issue24 facts ▸
- Other provision, “5:133CSA, no fairness opinion” (deed in French)
- Auditor report, 07-07-2022
- Capital contribution
- Share issue, “droits capitaux propres”, 46000032 (deed in French)
- Share issue, “droits capitaux propres”, 30666688 (deed in French)
- Other provision, “proces-verbal_assemblee_meme_jour, intervention” (deed in French)
- Share transfer, LOSANE → OLIPHARM (10 times)
- Other provision, “titres statut”, 100 (deed in French)
- Other provision, “belge, apporteur societes” (deed in French)
- Other provision, “societes listees” (deed in French)
- Other provision, “transfert”, 31-03-2022 (deed in French)
- Amendment of the articles, 5
- +12 further facts in this act
Show earlier events
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Check the withholding obligation If you pay this company for building or cleaning work, check before every payment whether you must withhold part of the invoice, with enterprise number 0840.562.012
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21614H0055/02P025 | Brussels | 2,515 m² | 1 · 234 m² | 12.1 m · 3 |
How the parcels are linked
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: “Responsabilite organe administration” (deed in French)
Read from the deeds: 1 provision, deed of 22-08-2022